 Angus Macnicol
Concepts (194)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA-Binding Proteins | 17 | 2025 | 133 | 5.430 |
Why?
| | Nerve Tissue Proteins | 14 | 2025 | 201 | 4.460 |
Why?
| | Protein Biosynthesis | 17 | 2025 | 267 | 4.160 |
Why?
| | Xenopus Proteins | 10 | 2025 | 34 | 3.540 |
Why?
| | RNA, Messenger | 17 | 2025 | 1134 | 2.740 |
Why?
| | Oocytes | 15 | 2025 | 95 | 2.280 |
Why?
| | Gene Expression Regulation | 8 | 2021 | 1004 | 1.850 |
Why?
| | Cell Cycle | 10 | 2019 | 236 | 1.800 |
Why?
| | Pituitary Gland | 6 | 2025 | 87 | 1.540 |
Why?
| | Leptin | 7 | 2025 | 148 | 1.440 |
Why?
| | Xenopus | 11 | 2014 | 41 | 1.390 |
Why?
| | 3' Untranslated Regions | 9 | 2021 | 54 | 1.370 |
Why?
| | Reproduction | 2 | 2021 | 66 | 1.330 |
Why?
| | Ribonucleoproteins | 7 | 2025 | 23 | 1.280 |
Why?
| | Somatotrophs | 6 | 2025 | 43 | 1.030 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2021 | 146 | 1.010 |
Why?
| | Animals | 36 | 2025 | 13485 | 1.000 |
Why?
| | Polyadenylation | 9 | 2019 | 21 | 1.000 |
Why?
| | Transcription Factor Pit-1 | 4 | 2025 | 17 | 0.910 |
Why?
| | Pituitary Gland, Anterior | 2 | 2021 | 36 | 0.850 |
Why?
| | Protein Processing, Post-Translational | 3 | 2024 | 152 | 0.850 |
Why?
| | Receptors, LHRH | 2 | 2021 | 12 | 0.830 |
Why?
| | Xenopus laevis | 6 | 2025 | 44 | 0.770 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2022 | 43 | 0.730 |
Why?
| | Pyrans | 1 | 2021 | 16 | 0.710 |
Why?
| | Adipocytes | 2 | 2021 | 127 | 0.690 |
Why?
| | Hypothalamus | 1 | 2021 | 41 | 0.690 |
Why?
| | Glioblastoma | 1 | 2022 | 89 | 0.680 |
Why?
| | Cell Cycle Proteins | 3 | 2012 | 168 | 0.680 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2021 | 28 | 0.680 |
Why?
| | Proto-Oncogene Proteins c-mos | 4 | 2012 | 8 | 0.680 |
Why?
| | Neoplastic Stem Cells | 1 | 2021 | 88 | 0.660 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2021 | 83 | 0.660 |
Why?
| | Stem Cells | 4 | 2021 | 186 | 0.650 |
Why?
| | Cell Lineage | 3 | 2021 | 92 | 0.650 |
Why?
| | Gonadotropins | 1 | 2019 | 9 | 0.630 |
Why?
| | Receptors, Leptin | 4 | 2025 | 52 | 0.620 |
Why?
| | Poly(A)-Binding Proteins | 1 | 2019 | 6 | 0.620 |
Why?
| | Brain Neoplasms | 1 | 2022 | 302 | 0.580 |
Why?
| | Cell Differentiation | 3 | 2019 | 667 | 0.540 |
Why?
| | Neural Stem Cells | 1 | 2015 | 25 | 0.450 |
Why?
| | Signal Transduction | 10 | 2025 | 1724 | 0.450 |
Why?
| | Polynucleotide Adenylyltransferase | 1 | 2014 | 2 | 0.430 |
Why?
| | Cells, Cultured | 6 | 2021 | 1583 | 0.410 |
Why?
| | Mice | 13 | 2025 | 5899 | 0.410 |
Why?
| | MAP Kinase Signaling System | 3 | 2012 | 128 | 0.410 |
Why?
| | Growth Hormone | 4 | 2025 | 96 | 0.390 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2012 | 15 | 0.380 |
Why?
| | Cell Line, Tumor | 4 | 2022 | 1429 | 0.380 |
Why?
| | Breast Neoplasms | 1 | 2021 | 1203 | 0.370 |
Why?
| | Growth and Development | 2 | 2018 | 14 | 0.370 |
Why?
| | Protein-Tyrosine Kinases | 2 | 2012 | 92 | 0.360 |
Why?
| | Cytoplasm | 5 | 2016 | 93 | 0.350 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2010 | 43 | 0.330 |
Why?
| | Female | 15 | 2025 | 28277 | 0.320 |
Why?
| | RNA, Messenger, Stored | 1 | 2009 | 4 | 0.320 |
Why?
| | Humans | 17 | 2025 | 52441 | 0.320 |
Why?
| | Genes, mos | 1 | 2008 | 3 | 0.290 |
Why?
| | Nuclear Proteins | 2 | 2008 | 247 | 0.290 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 2 | 2008 | 5 | 0.290 |
Why?
| | Oogenesis | 3 | 2019 | 19 | 0.260 |
Why?
| | Progesterone | 4 | 2012 | 60 | 0.260 |
Why?
| | Protein Binding | 2 | 2025 | 673 | 0.250 |
Why?
| | Rats | 4 | 2021 | 3228 | 0.250 |
Why?
| | Gonadotrophs | 2 | 2023 | 18 | 0.240 |
Why?
| | Phosphorylation | 2 | 2017 | 536 | 0.220 |
Why?
| | Transcription Factors | 2 | 2008 | 570 | 0.220 |
Why?
| | Pituitary Hormones | 1 | 2024 | 18 | 0.210 |
Why?
| | Growth Hormone-Releasing Hormone | 2 | 2020 | 26 | 0.210 |
Why?
| | Ghrelin | 2 | 2020 | 31 | 0.210 |
Why?
| | Transcriptional Activation | 1 | 2004 | 127 | 0.210 |
Why?
| | Base Sequence | 5 | 2014 | 632 | 0.200 |
Why?
| | Sesquiterpenes | 2 | 2014 | 89 | 0.200 |
Why?
| | Diet, High-Fat | 1 | 2025 | 230 | 0.200 |
Why?
| | Molecular Sequence Data | 5 | 2014 | 778 | 0.200 |
Why?
| | Blotting, Western | 4 | 2014 | 587 | 0.200 |
Why?
| | Monensin | 1 | 2022 | 7 | 0.190 |
Why?
| | DNA Primers | 4 | 2014 | 204 | 0.190 |
Why?
| | Organoids | 1 | 2022 | 35 | 0.190 |
Why?
| | Transcriptome | 1 | 2025 | 357 | 0.190 |
Why?
| | MCF-7 Cells | 1 | 2021 | 63 | 0.180 |
Why?
| | Adipokines | 1 | 2021 | 11 | 0.180 |
Why?
| | Estrus | 1 | 2021 | 14 | 0.180 |
Why?
| | Prolactin | 2 | 2018 | 41 | 0.170 |
Why?
| | Mice, 129 Strain | 1 | 2021 | 36 | 0.170 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2021 | 41 | 0.170 |
Why?
| | NIH 3T3 Cells | 1 | 2021 | 52 | 0.170 |
Why?
| | Receptors, Ghrelin | 1 | 2020 | 4 | 0.170 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2021 | 135 | 0.170 |
Why?
| | Ovary | 1 | 2021 | 101 | 0.170 |
Why?
| | Fasting | 1 | 2020 | 75 | 0.170 |
Why?
| | Testis | 1 | 2021 | 74 | 0.170 |
Why?
| | Cell Division | 1 | 2021 | 288 | 0.170 |
Why?
| | Drug Discovery | 1 | 2021 | 94 | 0.160 |
Why?
| | Tumor Microenvironment | 1 | 2022 | 257 | 0.160 |
Why?
| | Cell Movement | 1 | 2021 | 271 | 0.160 |
Why?
| | Aging | 1 | 2025 | 722 | 0.160 |
Why?
| | Time Factors | 4 | 2010 | 2987 | 0.160 |
Why?
| | Transcription, Genetic | 1 | 2021 | 375 | 0.160 |
Why?
| | Poly(A)-Binding Protein I | 1 | 2019 | 6 | 0.150 |
Why?
| | Mice, Transgenic | 1 | 2021 | 566 | 0.150 |
Why?
| | Sex Characteristics | 2 | 2018 | 210 | 0.140 |
Why?
| | Mice, Knockout | 4 | 2025 | 903 | 0.140 |
Why?
| | Protein Isoforms | 1 | 2017 | 127 | 0.130 |
Why?
| | Meiosis | 3 | 2007 | 70 | 0.130 |
Why?
| | Cytoplasmic Granules | 1 | 2016 | 17 | 0.130 |
Why?
| | Mitosis | 2 | 2014 | 87 | 0.120 |
Why?
| | G-Quadruplexes | 1 | 2016 | 77 | 0.110 |
Why?
| | Flow Cytometry | 1 | 2016 | 396 | 0.110 |
Why?
| | Cell Line | 1 | 2017 | 1020 | 0.110 |
Why?
| | DNA Damage | 1 | 2016 | 298 | 0.110 |
Why?
| | Molecular Targeted Therapy | 1 | 2015 | 135 | 0.110 |
Why?
| | Substrate Specificity | 1 | 2014 | 197 | 0.100 |
Why?
| | Models, Biological | 2 | 2010 | 735 | 0.100 |
Why?
| | Phylogeny | 1 | 2014 | 229 | 0.100 |
Why?
| | Progestins | 1 | 2012 | 13 | 0.100 |
Why?
| | Glutathione Transferase | 2 | 2004 | 174 | 0.090 |
Why?
| | Oligonucleotides, Antisense | 1 | 2012 | 29 | 0.090 |
Why?
| | RNA | 2 | 2004 | 174 | 0.090 |
Why?
| | Mammals | 1 | 2012 | 59 | 0.090 |
Why?
| | Sequence Analysis, DNA | 2 | 2014 | 220 | 0.090 |
Why?
| | Mutation | 2 | 2020 | 1331 | 0.090 |
Why?
| | Oxidative Stress | 1 | 2016 | 805 | 0.090 |
Why?
| | Evolution, Molecular | 1 | 2012 | 98 | 0.090 |
Why?
| | Male | 6 | 2021 | 26874 | 0.090 |
Why?
| | Systems Integration | 1 | 2010 | 15 | 0.080 |
Why?
| | Cyclin B2 | 1 | 2009 | 2 | 0.080 |
Why?
| | Cyclins | 1 | 2009 | 38 | 0.080 |
Why?
| | Thyrotropin | 2 | 2020 | 48 | 0.070 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2008 | 71 | 0.070 |
Why?
| | PC12 Cells | 1 | 2008 | 23 | 0.070 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2008 | 100 | 0.070 |
Why?
| | Subcellular Fractions | 1 | 2008 | 33 | 0.070 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2008 | 7 | 0.070 |
Why?
| | Species Specificity | 1 | 2008 | 194 | 0.070 |
Why?
| | Protein Transport | 1 | 2008 | 172 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 580 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 2 | 2012 | 177 | 0.070 |
Why?
| | Homeostasis | 1 | 2007 | 206 | 0.060 |
Why?
| | Response Elements | 1 | 2006 | 29 | 0.060 |
Why?
| | Adult | 1 | 2022 | 14205 | 0.060 |
Why?
| | Nucleic Acid Conformation | 1 | 2006 | 84 | 0.060 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 1216 | 0.060 |
Why?
| | Neurons | 1 | 2008 | 442 | 0.060 |
Why?
| | HeLa Cells | 2 | 2016 | 243 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2008 | 1013 | 0.050 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2004 | 48 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2004 | 129 | 0.050 |
Why?
| | Follicle Stimulating Hormone | 1 | 2023 | 40 | 0.050 |
Why?
| | CDC2 Protein Kinase | 1 | 2002 | 15 | 0.050 |
Why?
| | Blotting, Northern | 1 | 2002 | 107 | 0.050 |
Why?
| | Mutagenesis | 1 | 2002 | 58 | 0.050 |
Why?
| | Plasmids | 1 | 2002 | 162 | 0.050 |
Why?
| | Histones | 1 | 2004 | 315 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2023 | 312 | 0.040 |
Why?
| | Mothers | 1 | 2004 | 262 | 0.040 |
Why?
| | Endocrine System | 1 | 2020 | 16 | 0.040 |
Why?
| | DNA | 1 | 2004 | 544 | 0.040 |
Why?
| | Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2020 | 10 | 0.040 |
Why?
| | Receptors, Neuropeptide | 1 | 2020 | 11 | 0.040 |
Why?
| | Mice, Inbred C57BL | 1 | 2025 | 1888 | 0.040 |
Why?
| | Proteins | 1 | 2002 | 353 | 0.040 |
Why?
| | Sex Factors | 1 | 2020 | 735 | 0.040 |
Why?
| | Neoplasms | 1 | 2008 | 1314 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2018 | 355 | 0.030 |
Why?
| | Gene Deletion | 1 | 2018 | 279 | 0.030 |
Why?
| | Integrases | 1 | 2016 | 43 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2016 | 86 | 0.030 |
Why?
| | MicroRNAs | 1 | 2020 | 392 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 465 | 0.030 |
Why?
| | G2 Phase | 1 | 2014 | 14 | 0.030 |
Why?
| | Blotting, Southern | 1 | 2014 | 41 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2014 | 59 | 0.030 |
Why?
| | Heterocyclic Compounds | 1 | 2014 | 29 | 0.030 |
Why?
| | Zebrafish | 1 | 2014 | 61 | 0.030 |
Why?
| | Genetic Vectors | 1 | 2014 | 128 | 0.030 |
Why?
| | Chickens | 1 | 2014 | 107 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2014 | 399 | 0.030 |
Why?
| | Molecular Structure | 1 | 2014 | 317 | 0.020 |
Why?
| | Two-Hybrid System Techniques | 1 | 2012 | 28 | 0.020 |
Why?
| | Zinc Fingers | 1 | 2012 | 25 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2012 | 140 | 0.020 |
Why?
| | Binding Sites | 1 | 2012 | 379 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2012 | 576 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 1365 | 0.020 |
Why?
| | Calmodulin | 1 | 2007 | 10 | 0.020 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2007 | 16 | 0.020 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2007 | 137 | 0.020 |
Why?
| | Calcium | 1 | 2007 | 396 | 0.020 |
Why?
| | Retinoblastoma-Like Protein p107 | 1 | 2002 | 5 | 0.010 |
Why?
| | Retinoblastoma-Like Protein p130 | 1 | 2002 | 8 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2002 | 57 | 0.010 |
Why?
| | Phosphoproteins | 1 | 2002 | 123 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2002 | 378 | 0.010 |
Why?
|
|
Macnicol's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|